SG Americas Securities LLC Has $2.51 Million Position in The Chemours Company $CC

SG Americas Securities LLC raised its stake in The Chemours Company (NYSE:CC) by 261.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 219,576 shares of the specialty chemicals company’s stock after acquiring an additional 158,842 shares during the period. SG Americas Securities LLC owned approximately 0.15% of Chemours worth $2,514,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. SouthState Corp bought a new position in shares of Chemours in the first quarter worth $34,000. GAMMA Investing LLC grew its stake in Chemours by 130.7% during the second quarter. GAMMA Investing LLC now owns 3,175 shares of the specialty chemicals company’s stock worth $36,000 after buying an additional 1,799 shares in the last quarter. FNY Investment Advisers LLC grew its stake in Chemours by 100.0% during the second quarter. FNY Investment Advisers LLC now owns 4,000 shares of the specialty chemicals company’s stock worth $45,000 after buying an additional 2,000 shares in the last quarter. CWM LLC increased its holdings in Chemours by 34.7% in the 2nd quarter. CWM LLC now owns 4,290 shares of the specialty chemicals company’s stock valued at $49,000 after buying an additional 1,104 shares during the period. Finally, Parallel Advisors LLC raised its position in shares of Chemours by 132.6% in the 2nd quarter. Parallel Advisors LLC now owns 5,634 shares of the specialty chemicals company’s stock valued at $65,000 after buying an additional 3,212 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently issued reports on CC shares. Royal Bank Of Canada reduced their price target on shares of Chemours from $19.00 to $17.00 and set an “outperform” rating on the stock in a research report on Monday, November 10th. Zacks Research lowered Chemours from a “hold” rating to a “strong sell” rating in a research note on Friday, October 17th. Truist Financial lowered their price target on Chemours from $21.00 to $18.00 and set a “buy” rating for the company in a report on Monday, November 10th. Mizuho reduced their price objective on Chemours from $19.00 to $18.00 and set an “outperform” rating on the stock in a research note on Thursday, October 16th. Finally, UBS Group decreased their target price on Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Tuesday, November 11th. Five research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Chemours currently has an average rating of “Hold” and a consensus target price of $17.50.

Chemours Trading Down 2.6%

Shares of CC stock opened at $10.96 on Wednesday. The Chemours Company has a twelve month low of $9.13 and a twelve month high of $22.38. The stock’s fifty day simple moving average is $14.38 and its 200 day simple moving average is $13.23. The company has a quick ratio of 0.88, a current ratio of 1.71 and a debt-to-equity ratio of 13.66. The firm has a market capitalization of $1.64 billion, a P/E ratio of -4.94 and a beta of 1.64.

Chemours (NYSE:CC) last announced its quarterly earnings results on Thursday, November 6th. The specialty chemicals company reported $0.20 EPS for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.04). The firm had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.50 billion. Chemours had a negative net margin of 5.70% and a positive return on equity of 35.27%. The business’s revenue for the quarter was down .9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.40 earnings per share. Chemours has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, sell-side analysts predict that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Friday, November 14th will be issued a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date of this dividend is Friday, November 14th. Chemours’s payout ratio is presently -15.77%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.